The ARK Genomic Revolution ETF offers unique, actively managed exposure to innovative genomics companies, focusing on small- and mid-caps for high-growth potential. ARKG's active management and high ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an ...
ARK Genomic Revolution ETF (ARKG) maintains a "Buy" rating, driven by strong technicals and momentum despite a premium valuation. ARKG has outperformed XLV and SPY over the past year, returning 23% ...
Hosted on MSN
Cathie Wood’s ARK made just one buy last session — and it’s a biotech stock up nearly 30% YTD
・On Thursday, ARK bought a total of 56,769 shares of Intellia, with 48,178 shares purchased by its ARKK ETF and 8,591 shares through its ARKG ETF. ・NTLA stock was its top 23 investment as of Dec. 31, ...
Will ARKG outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.
U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...
The Ark Invest ETFs outperformed the S&P 500 in 2025 and investors looking to get in on some of Wood's picks may want to take a look at GeneDx Holdings Corp (NASDAQ: WGS). The gene-diagnostic testing ...
In trading on Thursday, the iShares U.S. Home Construction ETF is outperforming other ETFs, up about 3.8% on the day. Components of that ETF showing particular strength include shares of LGI Homes, up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results